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New mothers’ awareness of newborn screening, and their attitudes to 
the retention and use of screening samples for research purposes 
 




Aim: To explore new mothers’ knowledge of newborn screening, and their attitudes 
towards issues surrounding sample retention and the potential for blood screening 
samples to be used for research.  
 
Methods: A self-administered mail survey was sent to women who gave birth in 
Perth, Western Australia during January 2005. A total of 600 women completed the 
survey.  
 
Results: It was found that women were aware of newborn screening, however desired 
further information in order to acquire a more comprehensive knowledge of the test.  
Further, women reported discomfort with the long-term storage of cards, but they 
were supportive of using blood samples for medical research, contingent upon the 
samples being de-identified and parental consent provided.  
 
Conclusions: New mothers need to be provided with comprehensive information 
about the newborn screening test at a time which is conducive for the assimilation of 
this information. In addition, whilst supporting health related research using newborn 
screening samples, new mothers are keen for ethical issues to be sufficiently 
addressed prior to samples being systematically stored for extended periods of time.  
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For several decades the genetic blood screening of newborns to detect inborn errors of 
metabolism has been recognised as a valuable component of neonatal care in many 
developed countries around the world.1 2 The early detection of these disorders has 
proven an effective means by which interventions can be implemented to significantly 
reduce morbidity, mortality and associated disabilities.3 4 5 Publicly funded newborn 
screening programs have been operating in Australia since 1964, and although 
participation is entirely voluntary, there is high public participation in most 
programs1, enabling them to be cost effective.6 
 
At present Australian newborn screening programs are working towards developing a 
nationally consistent approach to the retention of newborn screening cards, and 
secondary uses of the blood samples derived from these cards. At the time of this 
study in 2005, retention periods still vary significantly across States, ranging from two 
years to indefinitely. Such considerable differences between programs is reflective of 
the situation internationally where there is no agreement on the appropriate retention 
period of newborn blood samples.2,7 Closely associated with sample retention periods 
is the issue of what, if any, secondary uses are appropriate for the blood samples 
collected for the sole purpose of newborn screening.  
 
While sample retention for forensic and quality assurance purposes, and for the 
development or modification of screening tests is justifiable, it is the potential for 
these samples to be used to conduct population based health screening studies and 
epidemiological research that prompts the need to articulate agreed standards in this 
area. It is very difficult to obtain population datasets of this kind that derive from the 
whole population with no selection.7 Consequently, the research opportunities are 
plentiful. In the United Kingdom, the value of conducting research based on blood 
samples gathered through newborn screening is acknowledged as having contributed 
towards answering important public health questions and leading to advancements in 
newborn and antenatal screening technologies.8   
 
At the same time, significant ethical issues underlie the ability to access blood 
samples derived from newborn screening, including the appropriateness of using 
samples obtained through dissent rather than informed consent for secondary 
purposes,2 and the ability to garner public support for such research. Biological 
specimen databanks are often met with great reservation by the public because of their 
potential for misuse and a lack of visible bodies to provide regulation.7 Further, these 
ethical issues may vary according to the levels of access researchers would be 
afforded, in particular whether they would have access to identified or de-identified 
samples. 
 
Ascertaining the views of the community, and parents in particular, about the retention 
and use of newborn blood samples forms a critical component of the development of 
any policy in this area. Such studies are a growing area of investigation within the 
psychology of newborn screening,9 although not yet explored extensively. To date 
these studies have targeted the parent’s levels of knowledge about the programs and 
any psychosocial issues related to the provision of positive test results for particular 
disorders.10 11 12 13 It is reasonable to anticipate that the attitudes of parents whose 
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child has been diagnosed through newborn screening may be different from those 
parents whose child was found not to have an inborn error of metabolism, or from the 
community in general.  
 
Although several factors influence parental views about newborn screening, parents 
have been found to be generally supportive of newborn screening programs, even in 
the case where false-positive test results have been given.4 Positive attitudes are not 
necessarily contingent upon adequate knowledge of screening, as there is substantial 
evidence suggesting that parents often have limited knowledge of which disorders are 
tested for, the effects of the disorders and the treatments available.9 Many new 
mothers are not even aware of the test being performed on their child.14 Further, a 
recent study has found that parents in the United States are not well informed about 
the storage of cards, or their potential uses, and only five percent of educational 
materials aimed at informing parents about newborn screening actually address these 
issues.15 Although data regarding attitudes towards storage and use of newborn 
screening samples is limited, Gustafsson Stolt et al (2002) report their respondents 
expressing concern about the storage of material and the right to be informed of any 
screening or project results.16  
  
In relation to using newborn blood samples for research purposes, data from Sweden 
suggests that mothers have generally positive attitudes to research. Those who choose 
to allow their child’s blood sample to be used for research cite the potential to 
contribute to research as the primary motivation for doing so.16 Those who do not 
allow participation often cite concerns about making decisions on behalf of their child 
regarding genetic material as a primary consideration.16 
 
The paucity of information about parental attitudes in relation to issues in newborn 
screening,13 has been identified as an issue requiring exploration. For policy 
development in particular, greater dialogue between government and community is 
necessary so that community concerns and any associated ethical issues may be 
adequately addressed.7,16 This study aims to explore new mothers’ knowledge and 
attitudes towards newborn genetic blood screening. Specifically, it aims to ascertain 
new mothers’ awareness of newborn screening, and their attitudes about issues 






Women who gave birth during the month of January 2005 were invited to participate. 




Information was collected via a self-administered mail survey, which women received 
four month’s after the birth of their child. Items included in the survey were 
constructed following a review of the literature. Further, the investigators met with a 
group of new mothers to ask them about their experience with newborn blood 
screening to inform survey construction. A pilot study was also conducted to verify 
ease of understanding. 
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The survey investigated four key areas, namely awareness of newborn screening, 
attitudes about appropriate retention periods for samples, attitudes towards the use of 
samples for secondary purposes specifically research, and demographic information. 
Participants were also given the opportunity to provide comments in order to enable 




Women meeting the inclusion criteria were selected from the Midwives Notification 
Database located at the Department of Health (Western Australia). These women were 
sent a copy of the survey, along with an information sheet detailing the method of 
participant selection, the purpose of the study, background information on newborn 
screening, and a reply paid envelope. Women were informed that completion and 
return of the survey was deemed consent to participate.  
 
The University of Western Australia Human Research Ethics Committee approved the 
study and the Confidentiality in Health Information Committee at the Department of 
Health, Western Australia granted access to the Midwives Notification Database. 
 
Data Analysis 
Descriptive statistics, Spearman’s Rank Order Correlation multiple response analysis 




The survey was sent to 1846 new mothers, of which 600 returned a completed survey, 
equating to a response rate of 33%. Although this response rate is typical for a self-
completed mail survey,17 and for new mothers in particular,18 an independent group of 
new mothers was sampled through seven new mother’s groups in the metropolitan 
area to check for bias in the study cohort. All new mothers present completed a short 
version of the mail survey (N = 52).  Demographic data were not collected on these 
new mothers. Responses from this sample were consistent with those obtained in the 
main survey. 
 
Ages ranged from 18 to 47 years with the mean age of the sample being 32 years. The 
number of children the women had ranged from one child to seven, with the average 
being two children. First time mothers comprised 44% of the sample. The majority of 
women lived within the metropolitan area (78%). Over a third of women had a 
university education (36%), and 27% reported that they had post-secondary school 
qualifications. 
 
To determine the representativeness of the sample, data from the Midwives 
Notification Database on all women who gave birth during January 2005 was 
obtained. Table 1 illustrates the differences between the population group and the 
sample collected. 
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Table 1. Comparison of population and sample demographics 
 
 Population (N = 1945) Sample (N = 600) 
Mean age 














   
 
 
Awareness of Newborn Genetic Blood Screening   
The majority of women (93%) stated that they had heard of newborn genetic blood 
screening prior to receiving the survey.  They reported receiving this information from 
a variety of sources (Table 2). 
 
Table 2. Respondent’s reported sources of information about newborn screening 
 
 Sources of information Most popular sources reported (%)  
 Midwife 
 Previous pregnancy 
 Newborn screening pamphlet 
 General practitioner or 
      obstetrician 







  1% 
 
Over half of all respondents were satisfied with the information provided (51%), with 
the remainder reporting higher (19%) or lower levels of satisfaction (18%). When 
provided with the opportunity to comment further, the women stated that the time at 
which the information was provided was a significant factor in determining their 
ability to adequately consider the information: 
 
I feel the test isn’t discussed enough at the time it is done. A midwife 
takes your baby, does the test, brings baby back and leaves a 
pamphlet that on most occasions gets put aside with all that’s going 
on. 
 
(The information) could have been lost in avalanche of other 
information and emotion.  
                       
Women also reported that they would have liked to receive more comprehensive 
information: 
 
Only very general information was given to me when the tests were 
done. I would have liked more detailed information (from midwife or 
information booklets).   
 
I don’t believe the information I received from my GP, Obstetrician, 
or hospital was adequate.    
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In order to gauge the extent to which women valued newborn genetic blood screening, 
they were asked to rate their agreement with the following statement: ‘I believe 
newborn blood screening is valuable for enabling the early detection of genetic 
disorders in children’. The majority either strongly agreed (61%) or agreed (34%). 
Only 5% stated that they either disagreed or held no opinion.  Women who had 
received information about newborn screening are more likely to value the screening 
test (.099, p = .017) and women’s belief in the value of newborn screening positively 
correlated with the degree to which they are satisfied with the information they were 
provided (.370, p = .000). 
 
Newborn Blood Sample Retention Periods 
Women were asked to nominate an appropriate time-period for retaining newborn 
blood samples before they are destroyed (Table 3). 
 
Table 3. Support for proposed newborn screening blood sample retention periods 
 
 Period of Retention Percentage of Respondents 
 2 years or less 
 3 – 10 years 
 11 – 20 years 
 21 years or more 
 Indefinitely 
 Unsure 









When asked to nominate reasons for their choice, women who believed in maintaining 
the retention period of two years spoke of not possessing adequate knowledge of the 
issues involved to justify deviating from current practice: 
 
I do not know a lot about the screening test nor have heard of 
reasons why they may be kept longer. Perhaps if I had more 
information my answer may be different. 
 
I don’t know enough about the information gathered from the 
screening to believe the timeframe should be different from the 
present period of two years.   
 
Other reasons for maintaining the current practice two-year retention period included 
statements that the time was adequate for the primary purpose of the test to be 
achieved and that this short period of time is a safeguard against any unnecessary 
research: 
 
My understanding is the disorders checked for occur in 
infancy…and two years should be adequate to gather data for any 
research needs.   
 
(Two years is appropriate) so information is gathered promptly and 
cards don’t just sit there waiting for someone to come up with 
something new to research. 
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Some women also distinguished between the results of the tests, believing that a 
longer period of retention could be justifiable for those samples, which test positive to 
enable research. 
 
Women who nominated between 3-10 years as being an appropriate retention period 
were keen to promote research on the samples, believing that this time enabled more 
research to take place. They also reported the belief that this period allowed for 
advancements in technology to enable the cards to be re-checked if necessary: 
 
It could provide a reference point if the child develops any problems 
beyond two years, plus it may be useful for future research which 
should be automatic unless parent specifies otherwise.                 
 
The longer retention periods of cards was also nominated because it is in keeping with 
standard record retention periods of between 5 to 10 years for important 
documentation, such as those required for taxation purposes. 
  
There was also support for a retention period of 21 years or longer (17%), the 
advantage of which was the facilitation of research opportunities. 
 
Attitudes towards the Use of Newborn Blood Samples for Research Purposes  
Most of the cohort (85%) believed that de-identified newborn screening samples 
should be made available for research, the remainder either disagreed (4%) or were 
unsure (11%).  
 
In order to gain an appreciation for the strength of women’s belief in the use of cards 
for research, they were asked the extent to which they agreed with the statement “I 
would agree to my baby’s card being used for research”. It was found that 85% of 
respondents either strongly agreed or agreed with the statement. A further 9% held no 
opinion, and 5% disagreed. In addition, 79% either strongly agreed or agreed with the 
statement “I would like to have the opportunity to contribute positively to research 
through newborn screening cards”. This sense of support for research was also 
reflected in the comments: 
 
Whatever information can be collected and research done on cards 
can only be of a benefit to medical community to better understand 
genetic diseases or other diseases that are influenced by lifestyle / 
environment. 
 
The women viewed de-identification of blood samples as a priority. It was found that 
when questioned about the importance of de-identifying blood samples for any 
purpose other than newborn screening, 90% of the sample agreed that this should 
occur. The importance of de-identification was also demonstrated through the 
comments provided: 
 
I am happy for my child's blood screening test to be used for 
research…as long as my child's identity and personal information is 
removed. 
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I feel strongly about ensuring that genetic details and information is 
kept private. Guaranteed privacy of genetic information would be 
essential to my support of any research.                          
 
Closely associated with this is their belief that parental consent should be sought prior 
to the samples being made available for research purposes:  
  
I feel strongly that consent should have to be given before samples 
are used for any purpose other than the specified genetic tests. 
 
Additionally, women were keen to receive information about the 
types of research that may be conducted so that they could make an 
informed decision as to whether the research is compatible with 
their ethical values: 
 
If this information was used for research I would like to know what type of research 
to decide if I agreed with it ethically and morally. 
 
I would be fine with use of sample for research if it was specifically outlined what the 
use would be and how the sample would be stored / destroyed / managed.          
 
In order to ascertain if women’s attitudes would be dependent upon the type of 
research that the samples could be used for, four research areas were listed and 
women were asked to nominate the extent to which they felt using the samples would 
be appropriate. These areas were (i) to understand the prevalence of disease in the 
community, (ii) to improve diagnostic tests for childhood diseases, (iii) to understand 
how lifestyle factors influence genetic diseases, and (iv) to improve diagnostic testing 
of diseases. All four areas were overwhelmingly supported. The most support was 
given to improving diagnostic tests for childhood diseases (97%), followed by 
improving diagnostic testing (96%), understanding prevalence of disease (93%), and 
lifestyle and genetic interactions (92%).  
 
When asked to nominate any types of research that would be unacceptable uses of 
newborn screening cards, the fields of uses most commonly cited were cloning, 
research that leads to abortion, ‘designer babies’, and the use of the information for 
paternity issues or criminal investigations.  
 
Further, women noted the need for necessary safeguards against inappropriate use to 
be in place prior any changes to current practice: 
 
I would be happy for my child’s card to be used for research but 
have concerns regarding the safety of personal and genetic 
information, and the relevance of the research. I wouldn’t want the 
cards kept for the purposes of doing research that does not directly 
benefit the community.            
 
Ethics is an important issue here and the availability of data to 
insurance companies, other family members, police etc without 
consent or by law is a problem not yet dealt with.                                                                              
 
Other Relationships 
No relationships between demographic factors and outcomes on the key variables 
were found.   
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This study investigated knowledge and attitudes of new mothers who had received no 
further information about newborn screening from the researchers, other than that 
presented in the newborn screening pamphlet, prior to completing the survey. In this 
way, the results generated provide a sound indication of the views of new mothers in 
Western Australia about issues relating to newborn screening and the potential use of 
screening samples for secondary purposes.  
 
The results suggest that women are aware of newborn screening, but do not feel that 
they are well informed. This echoes previous research indicating that new mothers 
possess limited awareness of the newborn screening test being performed,14 and its 
purpose, including the diseases being tested.9,19 Most women received screening 
information within the 72-hour period after the birth of their child. During this time, 
they receive a plethora of information relating to other aspects of neonatal care.  It is 
also common for midwives to perform the blood test away from the mother to 
circumvent any unnecessary anxiety,14 so it is not surprising that women may have 
difficulty assimilating screening information for a test for which they must ‘opt-out’. 
 
Previous studies have shown that the time at which screening information is provided 
was a critical determinant of women’s ability to adequately absorb the information. 
Therefore it may be more beneficial for health professionals to endeavour to provide 
this information during the prenatal period.2,15 In addition to facilitating the 
comprehension of the material, presenting information at this time would also enable 
more detail to be passed onto parents, and provide an opportunity for questions to be 
asked. Women were keen to receive additional newborn screening information 
through government pamphlets. Only a small proportion of women reported reading 
this pamphlet, and therefore it may be useful to ascertain if other forms of 
communicating this information may be more relevant for this group.   
 
Ensuring that women have adequate time to consider screening information becomes 
even more salient when considering the possibility of research on newborn blood 
samples. There was considerable support for the use of blood samples for research, 
and this support was motivated by the desire to make a positive contribution to 
research, mirroring results found for a similar cohort overseas.16 The women were 
also particularly supportive of research targeted at child health issues, indicating a 
belief that research on stored samples should be closely aligned with the primary 
purpose of the sample collection. However, support for research was contingent upon 
safeguards against breaches to privacy and policy makers need to be mindful of the 
public’s wariness of biobanks and ensure that the appropriate safeguards are in place 
prior to the systematic storage of newborn blood samples for extended periods. 
 
In relation to retention periods, the strong support of maintaining the current WA 
storage period of two years is to be expected. Without a thorough knowledge of the 
issues, determining a justification for nominating a longer time-period is difficult. 
Nevertheless, the women equally supported storage of between three to ten years to 
allow adequate time for research. The qualitative data also suggests that women are 
generally uncomfortable with the long-term retention of cards for research purposes. 
These results suggest that given appropriate justification, samples may be stored for 
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longer than the current two-year period, although storage beyond a decade is 
unsupported.    
 
There were specific aspects arising from this research which merit further 
investigation. In particular, this study did not collect information on whether any of 
the women participating had received either a positive or a false positive test result. 
Although the expected numbers for such results would be low, it would nevertheless 
be valuable to explore any differentiation between these groups from the core group 
across all variables. Secondly, the investigation of women’s awareness of screening 
could be explored in greater detail to gain an indication of women’s actual knowledge 
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